Research & Development: Page 84
-
PharmaVoice Team/PharmaVoice
Gene Therapy Research Makes Progress
With all the progress that has been made in genomics, targeting therapies to correct the defective genes responsible for disease seems quite realistic. But developing commercial gene therapies to treat diseases through modifying the expressions of an individual’s genes or correcting abnormal gene...
By Denise Myshko • Jan. 29, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
THE PRICE IS RIGHT Drug Pricing Decisions More Critical Than Ever In aneraofmore competition from generics, expiring patent protection for many topselling drugs, and a slowdown in new drug discoveries, there is very little margin for error in drug pricing decisions. Kalorama Information’s recent ...
By PharmaVoice Team • Jan. 29, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Wh o w o u l d h a v e thought that in 10 short years, we would have gone from Dolly to Elsie? In February 1997, scientists in Scotland announced the birth of the world’s first successfully cloned mammal, Dolly the sheep. Dolly, which was created at the Roslin Institute in Edinburgh, was actually...
By Taren Grom • Jan. 29, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions Pharma POOL Dr. Corey Goodman Dr. Martin Mackay Dr. Briggs Morrison Pfizer Announces Executive Changes Pfizer has launched an independent, stand-alone biotherapeutics and bioinnovation center under the direction of scientist and entrepreneur Corey Goodman, Ph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Internationally renowned vaccines, immunology, and virology expert Paul A. Offit, M.D., has dedicated his career to discovering vaccines to prevent infectious diseases, and is the co-inventor of the rotavirus vaccine, RotaTeq, developed by Merck. A pediatrician, author, and scientific researcher,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Thomson Scientific Offers Data Platform for Researchers Thomson Scientific has released BONDplus, an integrated, Web-based data platform designed to deliver real-time, comprehensive public and proprietary biological sequence, inte...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies inVentiv Health Creates Patient Outcomes Segment New division combines capabilities that help patients achieve optimum health. inVentiv Health has launched inVentiv Patient Outcomes, a business segment focused on helping pharmaceutical comp...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Events January 2008 January 15-16 2nd Annual Medical Science Liaison Skill Set Training Doubletree Hotel Philadelphia, Philadelphia For more information, contact Andrea Chadis, Center for Business Intelligence, at 781-939-2428, e-mail [email protected], or visit cbinet.com. January 15-...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Pharmacists Could Impact $145 Billion in Drug Sales in Five Years One state, Florida, already allows pharmacists to independently prescribe prescription drugs, and new research suggests six other states may soon give pharmacists this pow...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
When the Stars Align
By Robin Robinson The practice of using celebrities in marketing campaigns has not lost its luster, but the pharma industry is more selective in choosing icons who match brand images. As the industry approaches the 10th anniversary of the FDA’s ruling to allow DTC and subsequently the industry’s ...
By Robin Robinson • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Human Resource Related Issues
Otuska America Pharmaceutical’s Lorraine Daly, Leslie Eggleston, and Richard Obring discuss how HR issues, including compliance, compensation, and staffing can impact a pharmaceutical company’s culture. Otsuka’s Human Resources Department is responsible for more than 600 Otsuka employees in the U...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Craig A. DeLarge Craig A. DeLarge discusses Web 2.0’s drawbacks and opportunities. January 2008 Web 2.0 — Opportunities and Drawbacks n the last month, I have been intensely researching the Web 2.0 phenomenon with respect to its healthcare manifestations. This research has involved...
By Craig A. DeLarge • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Finding the Right Path -- Jane Hollingsworth
NuPathe cofounder and CEO Jane Hollingsworth has a fearless attitude about the risks involved in starting and running a business — and defines what it means to be an entrepreneur. Competitive by nature and with a fearless attitude when it comes to the risks involved in starting and running a busi...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
By Taren Grom, Editor I’m getting ready for Web. 2.0. Is your avatar up to date and ready to navigate the “new” World Wide Web? Web 2.0, social networking, or as the contributing author of this month’s Outlet refers to the recent phenomenon “the collective Web,” is seemingly on the tip of everyon...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Milestones In More than 1 Million Served InfoMedics Inc. recently reached a set of significant milestones, including the enrollment of the 1 millionth patient and 500,000th physician in the course of implementing more than 150 patient-physician communications programs for 14 of the top 15 pharmac...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Delivering New Hope
In a bid to tackle patient compliance, improve treatments, and maximize drug sales, companies are increasingly looking to emerging drug delivery technologies. By Kim Ribbink Necessity is the mother of invention. In the pharmaceutical industry “necessity” might be characterized as patent expiratio...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Doctors' Choice Awards
The doctors’ choice awards, an annual study conducted by the Association of Medical Media (formerly the Association of Medical Publications), is the only program that is voted on by the industry’s customers — the physicians. Winners are selected according to their scores in an independent Interne...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New Healthcare-related Products, Services, and Companies CommonHealth Seeks to Enhance Healthcare with Launch of EvoLogue The agency is focusing on evolving the healthcare dialogue. CommonHealth Consumer Group (CCG) has launched EvoLogue, a full-service consumer agency providing insigh...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
New Worlds of Opportunities Clinical Development
By Denise Myshko Technology will be the change agent for overhauling development processes to reduce costs and increase efficiencies. The development process needs to undergo a major overhaul to reduce costs and increase efficiencies to bring new medicines to market in a more timely manner. The c...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Medicare Part D
Industry experts evaluate the impact of Medicare Part D and project what further market- shaping events are to come. For consumers, the implementation of Medicare Part D has mostly been positive — reduced out-of-pocket costs and improved access to medicines. According to a study by The Amundsen G...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
An Industry Overview
BY ROBIN ROBINSON The strategic plans for 2008 in the industry appear to be business as usual, which may not bode well for its future, according to PricewaterhouseCoopers’ (PWC) latest report. According to Pharma 2020: The Vision report, to make the most of future growth opportunities, the indust...
By Robin Robinson • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Flawless Execution The most successful brand and product managers are the ones who look to their suppliers as partners rather than just “vendors” of a narrowly defined product or service. Kathleen A. Bonetti VP of Marketing LeveragePoint Media/Rx EDGE Raise Your Voice — Letters More than a vendor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Stem Cells
By Kim Ribbink Experts discuss the milestones that have been achieved and the implications for stem-cell therapeutics. The Stem of Hope New findings and understandings about the way stem cells operate and their potential in therapeutic development have led to real hope that there could soon be tr...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Then & Now
Thought leaders review their 2006 predictions in 2007. PharmaVOICE asked experts who participated in last year’s issue to review their predictions for 2007 and evaluate whether their forecasts came to fruition and why or why not. (Editor’s Note: Predictions are presented in alphabetical order by ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Basic Research
New tools and technologies will provide new ways of looking at diseases, which could lead to a pipeline of new products. Start with the end in mind: patients. Leaders in drug discovery and research say this should guide how the biopharmaceutical industry approaches new medicines now and in the fu...
By Denise Myshko • Jan. 2, 2008
Previous
